Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: September 2011

Chapter 9 - Ultrasonography and diagnosis of polycystic ovary syndrome

from Section 2: - Ultrasonography in infertility


Ultrasound examination is now considered as part of almost every clinic setting. The creation of an image from sound is achieved in three steps: producing a sound wave, receiving echoes, and interpreting those echoes. The four different modes of ultrasound used in medical imaging are: A-mode, B-mode, M-mode and Doppler mode. The Doppler frequency shift information can be displayed graphically in various ways that include color Doppler (directional Doppler), power Doppler, and spectral (pulsed) Doppler. The different modes of Doppler waves include: Continuous-wave Doppler (CW) and Pulsed-wave Doppler (PW). The blood flow measurements are performed by calculation of velocity, calculation of absolute flow and flow waveform analysis. Despite its impressive safety record of ultrasound to date, the intensity (or acoustic output) level of ultrasound used to scan the fetus in utero has increased almost eightfold over the level that was allowed in the early 1990s.


1. CarminaE, LoboRA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84: 1897–9.
2. SteinIF, LeventhalML.Amenorrhea associated with polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181–91.
3. AzzizR, MarinC, HoqL, BadamgaravE, SongP. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 2005; 90: 4650–8.
4. ZawadskiJK, DunaifA. Diagnostic criteria for polycystic ovary syndrome: toward a rational approach. In: DunaifA, GivensJR, HaseltineFP, MerriamGR, eds., Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific, 1992, pp. 377–84.
5. Azziz, R. Controversy in clinical endocrinology: diagnosis of polycystic ovary syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006; 91: 781–5.
6. AzzizR, CarminaE, DewaillyD, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237–45.
7. LegroR, ChiuP, KunselmanAR, BentleyCM, DodsonWC, DuanifA.Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 2005; 90: 2571–9.
8. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term heath risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–7.
9. BalenA, LavenJSE, TanSL, DewaillyD. Ultrasound assessment of the polycystic ovary: international census definitions. Hum Reprod 2003; 9: 505–14.
10. JonardS, RobertY, Cortet-RudelliC, PignyP, DecanterC, DewaillyD. Ultrasound examination of polycystic ovaries: is it worth counting the follicles?Hum Reprod 2003; 18: 598–603.
11. AdamsJ, PolsonDW, FranksS. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J. 1986; 293: 355–9.
12. FoxR, CorriganE, ThomasPA, HullMG. The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin Endocrinol (Oxf) 1991; 34: 127–31.
13. JarvelaIY, MasonHD, SladkeviciusR, et al. Characterization of normal and polycystic ovaries using three-dimensional power doppler ultrasonography. J Assist Reprod Genet 2002; 19: 582–90.
14. LamPM, JohnsonIR, Raine-FenningNJ. Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod 2007; 22: 3116–23.
15. ZaidiJ, TanSL, PitroffR, CampbellS, CollinsW. Blood flow changes in the intra-ovarian arteries during the peri-ovulatory period–relationship to the time of day. Ultrasound Obstet Gynecol 1996; 7: 135–40.
16. BrownMA, ChangRJ.Polycystic ovary syndrome: clinical and imaging features. Ultrasound Q 2007; 23: 233–8.
17. DewaillyD, Catteau-JonardS, ReyssAC, Maunoury-LefebvreC, PonceletE, PignyP. The excess in 2–5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome. Hum Reprod 2007; 22: 1562–6.
18. JonardS, RobertY, DewaillyD. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod 2005; 20: 2893–8.
19. NagamaniM. Polycystic ovary syndrome variants: Hyperthecosis. In: AdashiEY, RockJA, RosenwaksZ, eds. Reproductive Endocrinology, Surgery and Technology. Philadelphia, PA: Lippincott-Raven, 1996; 1258–69.
20. DewaillyD, RobertY, HelinY, et al. Ovarian stromal hypertrophy in hyperandrogenic women. Clin Endocrinol (Oxf) 1994; 41: 557–62.
21. FulghesuAM, CiampelliM, BelosiC, ApaR, PavoneV, LanzoneA. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril 2001; 76: 326–31.
22. FulghesuAM, AngioniS, FrauE, et al. Ultrasound in polycystic ovary syndrome–the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod 2007; 22: 2501–8.
23. BelosiC, SelvaggiL, ApaR, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?Hum Reprod 2006; 21: 3108–15.
24. BuckettWM, BouzayenR, WatkinKL, TulandiT, TanSL.Ovarian stromal echogenicity in women with normal and polycystic ovaries. Hum Reprod 1999; 14: 618–21.
25. OzkanS, VuralB, CaliskanE, BodurH, TurkozE, VuralF. Color doppler sonographic analysis of uterine and ovarian artery blood flow in women with PCOS. J Clin Ultrasound 2007; 35: 305–13.